Coronavirus:
News
-
28 May 2020
Aerpio and Quantum Leap to study razuprotafib for ARDS in Covid-19
Aerpio Pharmaceuticals has partnered with Quantum Leap Healthcare Collaborative to assess razuprotafib in the I-SPY COVID trial to treat acute respiratory distress syndrome (ARDS) in adults with moderate to severe...
-
28 May 2020
Roche begins trial of Actemra plus remdesivir to treat Covid-19
Roche has started a Phase III clinical trial to assess its Actemra/RoActemra in combination with Gilead Sciences' remdesivir to treat hospitalised Covid-19 patients with severe pneumonia.
-
27 May 2020
Montefiore and Einstein assess remdesivir and baricitinib for Covid-19
Researchers at Montefiore Health System and Albert Einstein College of Medicine in the US have started a clinical trial to assess antiviral drug remdesivir plus rheumatoid arthritis medication baricitinib to...
-
26 May 2020
Synairgen launches SG016 trial of SNG001 for Covid-19 treatment
UK-based respiratory drug discovery and development firm Synairgen has confirmed the launch of a home-based clinical trial of its inhaled interferon-beta-1a in patients with coronavirus (Covid-19).
-
26 May 2020
COVID-19 concerns increase in May following easing of lockdowns
The COVID-19 concern index, as measured by responses to an ongoing poll launched by Verdict in March, has been tracking how the concerns over coronavirus have been changing over time....
-
26 May 2020
Glenmark starts Phase III Favipiravir combination study for Covid-19
Glenmark Pharmaceuticals has launched a Phase III clinical trial to assess Favipiravir in combination with antiviral drug Umifenovir for the treatment of Covid-19 in India.
-
26 May 2020
WHO halts hydroxychloroquine Covid-19 trial over safety concerns
The World Health Organization (WHO) has temporarily suspended a clinical trial of the malaria drug hydroxychloroquine in Covid-19 patients over safety concerns, according to the organisation’s director-general Dr Tedros Adhanom...
-
26 May 2020
Novavax begins Phase I/II trial of Covid-19 vaccine in Australia
US-based biotechnology firm Novavax has started enrolling participants in a Phase I/II clinical trial of its Covid-19 vaccine candidate, NVX‑CoV2373, in Australia.
-
22 May 2020
Amarin supports trial on effects of Vascepa in Covid-19 treatment
Biopharmaceutical firm Amarin has announced support for a clinical trial to investigate the effects of Vascepa on inflammatory biomarkers and other patient outcomes in patients with coronavirus (Covid-19) infection.
-
22 May 2020
UK researchers start trial of hydroxychloroquine to prevent Covid-19
Researchers at the University of Oxford in the UK are leading an international clinical trial to assess hydroxychloroquine for potentially preventing Covid-19 in frontline healthcare workers.